Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Corneal Epithelial Wound Healing
Interventions
DRUG

dexpanthenol and hyaluronic acid preservative-free eye artificial tears eye drops

Subjects will receive 1 drop of a hyaluronic acid preservative-free eye artificial tears eye drops (HA) as PLACEBO hourly during the day, but at least 12 times a day, until complete reepithelialization. Composition: 1 ml contains Sodium Hyaluronate 0.15 %, Sodium Chloride, Sodium Citrate, Citric Acid, Water for Injections Dosage Form: Single-dose container (0.5 mL)

DRUG

Placebo

Subjects will receive 1 drop of a hyaluronic acid preservative-free eye artificial tears eye drops (HA) as PLACEBO hourly during the day, but at least 12 times a day, until complete reepithelialization. Composition: 1 ml contains Sodium Hyaluronate 0.15 %, Sodium Chloride, Sodium Citrate, Citric Acid, Water for Injections Dosage Form: Single-dose container (0.5 mL)

Trial Locations (1)

11527

National and Kapodistrian University of Athens, Athens

All Listed Sponsors
lead

National and Kapodistrian University of Athens

OTHER